bullish
Hutchison-China Meditech (和黄医药) Placement: Big Discount After HK Listing Delayed
530 Views28 Jun 2019 16:51
HCM, a leading China biotech company, filed a prospectus to sell 8.5 million secondary ADSs. We have covered the company's fundamentals for its...
SUMMARY
(Sign Up to Access)Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
- Unlock research summaries
- Follow top, independent analysts
- Receive personalised alerts
- Access Analytics, Events and more
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.
or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Discussions
(Paid Plans Only)
Price Chart(Sign Up to Access)
- ECM Weekly (2 Feb 2020) - Smoore, Innocare, Kilcoy Global, Mr. DIY02 Feb 2020
- ECM Weekly (26 Jan 2020) - Central Retail Corp, Smoore, Mindspace Biz Parks REIT, Elite Comm REIT26 Jan 2020
- Hutchison-China Meditech Placement: Catalysts to Expect but Keep Overhang in Mind22 Jan 2020
- Hutchison-China Meditech (和黄医药) H-Share Listing: MNC Partnerships Endorsed Its R&D Capabilities25 Apr 2019
x